about
Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration.Stem cell based gene therapy in prostate cancerEradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.DDMC-p53 gene therapy with or without cisplatin and microwave ablation.Targeted polymeric nanoparticles for cancer gene therapy.A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells.Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy.Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy.Cytotoxic effect of co-expression of human hepatitis A virus 3C protease and bifunctional suicide protein FCU1 genes in a bicistronic vector.Cytosine deaminase as a negative selectable marker for the microalgal chloroplast: a strategy for the isolation of nuclear mutations that affect chloroplast gene expression.The impact of γ-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use.A novel suicide gene therapy for the treatment of p16Ink4a-overexpressing tumors.Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.Outlook and future of inner ear therapyTargeted nonviral gene therapy in prostate cancer
P2860
Q33556564-903B9968-FE86-49A6-B3BB-0DB7F730D888Q33909634-F4170789-86A6-4F57-8CD2-D34F661202E3Q33997951-5703595F-D853-4FA5-84C8-B2D8C628F3E3Q35109273-7CEA38E6-EDE8-4E44-A65C-7D51BF040F7EQ35127438-B97D352C-A6A9-4554-9205-5E37292235BEQ35176800-5082FB8A-B933-4BDD-B72C-F0AB54A6C3DAQ35654976-11D4C524-EB1D-4660-BEC2-5813BFDB71AAQ36416427-BCF56805-9E33-44DE-93D4-D7A5A9597A42Q36825943-8ACF77A7-FB9B-4A83-B105-306C2C25111BQ37012358-58A419F8-371C-440F-A64E-30576E138679Q39094451-219B6FE7-5BD6-4E09-AFAA-E09AC72C5D46Q40106600-EF201BFE-30F4-4E4F-BFA4-75B912BF993AQ43088855-6BDAEF22-A5F0-4E83-A078-408464262EC5Q45420119-79D36D6D-C951-47D4-91FB-C843BF7FCED8Q51767068-0CC4DAEE-A44C-453C-AF04-6258EDA35D19Q54112053-167CD275-A8FA-4F7B-990A-B9ECCAAF1CAFQ57139394-D607185B-D2AD-4D99-BF5E-2985D771C583Q57492228-62BB21A6-F0FA-4F71-81B4-0871DC188149
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suicide Gene Therapy for Cancer - Current Strategies.
@en
Suicide Gene Therapy for Cancer - Current Strategies.
@nl
type
label
Suicide Gene Therapy for Cancer - Current Strategies.
@en
Suicide Gene Therapy for Cancer - Current Strategies.
@nl
prefLabel
Suicide Gene Therapy for Cancer - Current Strategies.
@en
Suicide Gene Therapy for Cancer - Current Strategies.
@nl
P2093
P2860
P921
P1476
Suicide Gene Therapy for Cancer - Current Strategies.
@en
P2093
Antonios Sakkas
Haidong Huang
Kaid Darwiche
Konstantinos Zarogoulidis
Lonny Yarmus
Lutz Freitag
Marek Malecki
Paul Zarogoulidis
P2860
P356
10.4172/2157-7412.1000139
P577
2013-08-01T00:00:00Z